Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theratechnologies (TH.TO)

Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theratechnologies 2015, rue Peel 11th Floor Montreal QC H3A 1T8 CAN

https://www.theratech.com P: 514-336-7800 F: 514-331-9691

Sector:

Medical

INDUSTRY GROUPING:

TSX Biotechnology

Description:

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Key Statistics

Overview:

Market Capitalization, $K 205,531
Shares Outstanding, K 45,980
Annual Sales, $ 85,866 K
Annual Net Income, $ -8,306 K
Last Quarter Sales, $ 17,729 K
Last Quarter Net Income, $ -4,462 K
60-Month Beta -1.01
% of Institutional Shareholders 0.47%

Growth:

1-Year Return 166.07%
3-Year Return -65.93%
5-Year Return -61.60%
5-Year Revenue Growth 6.32%

Per-Share Information:

Most Recent Earnings -0.09 on 07/09/25
Next Earnings Date 12/04/25
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Qtr 200.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 07/31/23

TH.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -15.08%
Profit Margin % -9.67%
Debt/Equity N/A
Price/Sales 1.88
Price/Book N/A
Book Value/Share -0.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar